24 June 2024 - Revelation Biosciences Inc (NASDAQ: REVB), a clinical-stage life sciences company, on Monday announced positive safety and biomarker data from its Phase 1 clinical study of Gemini (RVL-HV02), Revelation's proprietary TLR4 agonist....
24 June 2024 - Bioscience company ChromaDex Corp (NASDAQ: CDXC) reported on Monday that it has achieved successful outcomes from a phase II clinical trial demonstrating the efficacy of Niagen (nicotinamide riboside or NR) in improving functional mobi...
24 June 2024 - Pre-clinical-stage pharmaceutical company MIRA Pharmaceuticals Inc (NASDAQ:MIRA) on Monday unveiled promising preclinical results for Ketamir-2, its oral ketamine analog.Unlike traditional ketamine, Ketamir-2 does not induce hyperlocom...
24 June 2024 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Monday that it has secured its second approval for IXCHIQ, its single-dose chikungunya vaccine.Health Canada authorised IXCHIQ for preventing chikungunya in adu...
24 June 2024 - Indian pharmaceutical company Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) (BSE:524715) confirmed on Monday that it has completed its merger with Taro Pharmaceutical Industries Ltd (NYSE:TARO), an Israeli research-based pharma...